For further reading: https://t.co/0q5ROlEV2c
Just came across this great review by @SMImmunology on the topic of TMB and ICB responses. Specifically highlighting the relation to T cell-inflamed versus non-T cell-inflamed tumors. #immunotherapy Check it out: https://t.co/eQXRMkCgRA
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/CwXL3dNc10 #
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer | Full Text https://t.co/cWnqwSy8rI
What is the interplay between hot/cold tumours and low/high mutational burden tumours in response to #immune checkpoint inhibitors? https://t.co/g3osATJYT4 via @BioMedCentral @WesternU @lawsonresearch #cancer #immunotherapy Image: Vareki 2018 https://t.co/
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
Understanding about mutational burden is getting better day by day. #cancertreatment #immunotherapy
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
#JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/aIUMxz1oaD https://t.co/ZYMVb1GEO3
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
#JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/aIUMxz1oaD https://t.co/rf3nGoFpEA
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
RT @sitcancer: #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune ch…
#JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/aIUMxz1oaD https://t.co/5JqhKOssUg
RT @SMImmunology: Assessing T-cell profile of the tumor should become common practice along with examining tumor genotypes in patients who…
RT @OmidHamidMD: Need for better #biomarkers in NC=C https://t.co/TSRxvtcXZ9
Need for better #biomarkers in NC=C
RT @SMImmunology: Assessing T-cell profile of the tumor should become common practice along with examining tumor genotypes in patients who…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @SMImmunology: Assessing T-cell profile of the tumor should become common practice along with examining tumor genotypes in patients who…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer | Full Text https://t.co/aFBtJl7cAR
Assessing T-cell profile of the tumor should become common practice along with examining tumor genotypes in patients who are considered for immunotherapy and access to the pateint tumor is possible for sequening. I discussed this in a commentary in JITC ht
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
RT @sitcancer: New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immun…
New #JITC Commentary: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/aIUMxz1oaD https://t.co/JiWLjzXTi2
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/qjywNmno2m
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @mlazqui: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors…
RT @TimAllenMDJD: "High TMB tumors often have higher levels of neoantigens that can be recognized by the immune system. In the current era…
RT @mlazqui: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors…
RT @mlazqui: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/GysVTl6qbf
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @mlazqui: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
RT @susanahprieto: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhib…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/ncnmv2nhge
RT @TimAllenMDJD: "High TMB tumors often have higher levels of neoantigens that can be recognized by the immune system. In the current era…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @mlazqui: High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors https://t.co/9XBkyZupis
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @TimAllenMDJD: "High TMB tumors often have higher levels of neoantigens that can be recognized by the immune system. In the current era…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @TimAllenMDJD: "High TMB tumors often have higher levels of neoantigens that can be recognized by the immune system. In the current era…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @TimAllenMDJD: "High TMB tumors often have higher levels of neoantigens that can be recognized by the immune system. In the current era…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
Carga mutacional vs fenotipo inmunológico como biomarcadores de respuesta a la inmunoterapia. Buena revisión 🤓 https://t.co/PEReQJZwDt
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…
RT @SMImmunology: My commentary on the importance of understanding and making a distinction between a tumor's genomic profile and its immun…